Astrana Health, Inc. (FRA:3AM)
Germany · Delayed Price · Currency is EUR 20.60
-1.80 (-8.04%)
Last updated: Jan 27, 2026, 3:25 PM CET
Astrana Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 9.54 | 43.15 | 60.72 | 45.17 | 68.92 | 37.69 |
Depreciation & Amortization | 37.47 | 27.93 | 17.75 | 17.54 | 17.52 | 18.35 |
Other Amortization | 3.35 | 1.83 | 1.06 | 0.94 | 1.08 | 1.35 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.09 |
Loss (Gain) From Sale of Investments | -0.73 | -0.73 | 3.34 | 19 | 25.45 | -99.83 |
Loss (Gain) on Equity Investments | -4.45 | -4.45 | -5.58 | -5.62 | 4.31 | -3.69 |
Stock-Based Compensation | 42.45 | 34.54 | 22.04 | 16.1 | 6.75 | 3.38 |
Other Operating Activities | 12.31 | 13.55 | -7.71 | -9.05 | -20.04 | 84.79 |
Change in Accounts Receivable | -44.39 | -44.39 | -26.74 | -38.19 | -1.52 | 4.13 |
Change in Accounts Payable | -30.92 | -30.92 | -0.17 | -0.05 | 3.22 | 8.2 |
Change in Income Taxes | -8.62 | -8.62 | -14.48 | 6.92 | -14.01 | -7.08 |
Change in Other Net Operating Assets | 90.52 | 20.32 | 17.99 | 29.37 | -21.33 | -1.22 |
Operating Cash Flow | 106.54 | 52.2 | 68.23 | 82.13 | 70.34 | 46.16 |
Operating Cash Flow Growth | 29.22% | -23.49% | -16.93% | 16.77% | 52.36% | 237.62% |
Capital Expenditures | -9.57 | -8.03 | -28.53 | -22.94 | -19.22 | -1.16 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.05 |
Cash Acquisitions | -579.32 | -146.26 | -6.51 | -16.35 | 3.34 | -11.35 |
Investment in Securities | 12.62 | -8.45 | -6.69 | 27.71 | 32.37 | 91.61 |
Other Investing Activities | -19.28 | -29.65 | -23.8 | 4.47 | 0.06 | 16.5 |
Investing Cash Flow | -571.27 | -192.4 | -65.52 | -7.11 | 16.54 | 95.49 |
Long-Term Debt Issued | - | 171.88 | 284.53 | 3.6 | 180.57 | - |
Long-Term Debt Repaid | - | -27.71 | -205.36 | -4.43 | -238.53 | -9.61 |
Total Debt Repaid | -496.29 | -27.71 | -205.36 | -4.43 | -238.53 | -9.61 |
Net Debt Issued (Repaid) | 623.02 | 144.16 | 79.17 | -0.83 | -57.97 | -9.61 |
Issuance of Common Stock | 1.03 | 1.03 | 1.52 | 8.63 | 9.06 | 10.8 |
Repurchase of Common Stock | -7.19 | -5.6 | -10.19 | -9.25 | -5.74 | -0.54 |
Common Dividends Paid | -5.65 | - | -62.07 | -14.03 | -31.09 | -51.32 |
Other Financing Activities | -30.79 | -4.44 | -5.01 | -4.61 | 37.98 | -1.04 |
Financing Cash Flow | 580.42 | 135.15 | 3.42 | -20.09 | -47.75 | -51.7 |
Net Cash Flow | 115.69 | -5.05 | 6.13 | 54.93 | 39.13 | 89.96 |
Free Cash Flow | 96.96 | 44.17 | 39.7 | 59.19 | 51.11 | 45 |
Free Cash Flow Growth | 38.74% | 11.26% | -32.93% | 15.80% | 13.58% | 256.26% |
Free Cash Flow Margin | 3.35% | 2.17% | 2.86% | 5.17% | 6.60% | 6.55% |
Free Cash Flow Per Share | 1.98 | 0.92 | 0.85 | 1.30 | 1.13 | 1.20 |
Cash Interest Paid | 37.41 | 30.42 | 14.25 | 6.67 | 4.16 | 8.51 |
Cash Income Tax Paid | 10.39 | 43.94 | 56.57 | 47.31 | 37.2 | 62 |
Levered Free Cash Flow | 208.4 | 65.38 | 74.56 | 88.27 | 33.57 | 106.21 |
Unlevered Free Cash Flow | 230.35 | 84.24 | 83.57 | 92.29 | 35.87 | 110.8 |
Change in Working Capital | 6.6 | -63.61 | -23.39 | -1.96 | -33.64 | 4.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.